Author:
Doulberis M,Papaefthymiou A,Polyzos S.A.,Vardaka E,Tzitiridou-Chatzopoulou M,Chatzopoulos D,Koffas A,Papadopoulos V,Kyrailidi F,Kountouras J
Abstract
Hepatitis A virus (HAV) represents a global burdening infectious agent causing in the majority of cases a self-limiting acute icteric syndrome, the outcome is related to the hepatic substrate and the potential pre-existing damage, whereas a plethora of extra-hepatic manifestations has also been reported. Despite the absence of post- HAV chronicity it has been associated with an additional burden on existing chronic liver diseases. Moreover, the induced immune response and the antigenic molecular mimicry are considered as triggering factors of autoimmunity with regional and distal impact. Diseases such as autoimmune hepatitis, Guillain-Barré syndrome, rheumatoid arthritis, Still’s syndrome, Henoch-Schönlein purpura, autoimmune hemolytic anemia, antiphospholipid syndrome, systematic lupus erythematosus or cryoglobulinemic vasculitis have been described in patients with HAV infection. Although the exact mechanisms remain unclear, this review aims to accumulate and clarify the pathways related to this linkage.
Reference68 articles.
1. LEMON SM, OTT JJ, VAN DAMME P, SHOUVAL D. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J. Hepatol, 2018, 68:167-184.
2. KANDA T, SASAKI R, MASUZAKI R, TAKAHASHI H, MIZUTANI T, MATSUMOTO N, et al. Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease. Int J Mol Sci, 2020, 21:6384.
3. Widespread person-to-person outbreaks of hepatitis A across the United States. https://www.cdc.gov/hepatitis/outbreaks/2017March-HepatitisA.htm (2022)
4. JACOBSEN KH. Globalization and the Changing Epidemiology of Hepatitis A Virus. Cold Spring Harb Perspect Med, 2018, 8:a031716.
5. JEONG S-H, LEE H-S. Hepatitis A: Clinical Manifestations and Management. Intervirology, 2010, 53:15-19.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献